Parameters | Intervention N (%) Mean ± SD | Placebo N (%) Mean ± SD | P value |
---|---|---|---|
Female | 5 (27.8%) | 4 (26.7%) | 0.627 |
Male | 13 (72.2%) | 11 (73.3%) | |
Premenopausal women | 2 (11.1%) | 2 (13.33%) | 0.643 |
Age (y) | 51.22 c 13.53 | 45.60 ± 15.50 | 0.275 |
Female age(y) | 48.00 ± 10.24 | 34.75 ± 14.93 | 0.157 |
Male age(y) | 52.46 ± 14.785 | 49.55 ± 14.32 | 0.630 |
Time on dialysis(months)a | 24.00 (22.00) | 22.00 (12.5) | 0.400 |
End stage renal disease etiology N (%) | Â | 0.828 | |
 Hypertensive disease | 8 (44.4) | 9 (60) | |
 Diabetic nephropathy | 4 (22.2) | 3 (20) | |
 Glomerulonephritis/vasculitis | 1 (5.6) | 0 (0) | |
 Cystic/hereditary/congenital diseases | 1 (5.6) | 0 (0) | |
 Other | 4 (22.2) | 3 (20) | |
Estimated glomerular filtration rate before transplant (ml/min) | 11.265 ± 4.891 | 10.716 ± 3.992 | 0.742 |
Physical activity (total METs)a | 321.75(618.75) | 198 (643.5) | 0.919 |